KITLG and osteonecrosis: Earlier studies have demonstrated the potent enhancing effect of SCF on osteoclast activity in vitro (61), and glucocorticoids, one of the causative agents of pharmacologic osteonecrosis, also increase the expression of SCF in various ways (62), which may reveal one of the key pathogenetic mechanisms of drug-induced osteonecrosis.